de.mpg.escidoc.pubman.appbase.FacesBean
English
 
Help Guide Disclaimer Contact us Login
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Cancer stem cells in melanoma

MPS-Authors
http://pubman.mpdl.mpg.de/cone/persons/resource/persons50487

Regenbrecht,  C. R. A.
Molecular Embryology and Aging (James Adjaye), Dept. of Vertebrate Genomics (Head: Hans Lehrach), Max Planck Institute for Molecular Genetics, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons50054

Adjaye,  J.
Molecular Embryology and Aging (James Adjaye), Dept. of Vertebrate Genomics (Head: Hans Lehrach), Max Planck Institute for Molecular Genetics, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Regenbrecht, C. R. A., Welte, Y., Hugel, R., Trefzer, U., Losch, F. O., Adjaye, J., et al. (2008). Cancer stem cells in melanoma. Ecancermedicalscience, 2, 114-114. doi:10.3332/ecancer.2008.114.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0010-7E9E-B
Abstract
The identification of cancer stem cells in various malignancies led to the hypothesis that these cells have the exclusive ability of self-renewal, contribute to the plasticity of the tumours and may be the cause for ineffective cancer therapies. Several markers of melanoma stem cells have been described in recent studies including CD133, CD1661, Nestin and BMI-12. Further studies are necessary to identify, better define, and understand origin and function of cancer stem cells. If confirmed that cancer stem cells play an important role in malignancy, therapeutic strategies may need to be redirected towards these cells to circumvent the failure of conventional therapies.